Artificial intelligence grabbed most of the headlines last year, but weight loss stocks were equally noteworthy. It grew slowly for several years but really went stratospheric last year.
The wider availability of Ozempic and Wegovy set the world on fire. A class of drugs known as glycogen-like peptide-1 (GLP-1) therapies for diabetes and obesity, demand was fueled by celebrities and social media influencers touting their slimming effects. They also spurred further investment into weight-loss-in-a-pill because why eat healthy and exercise?
Several pharmaceuticals are now pursuing alternatives to the twin blockbuster remedies, so let’s look at which of the leading weight loss stocks might be the best investment.
This post appeared first on InvestorPlace.